Blog Archives

ACCOUNTING FOR FUTURE PRICE REDUCTIONS CAUSED BY INCREASING ADOPTION OF MEDICAL DEVICES: IMPACT ON HTAs

Value in Health - Sept-Oct 2016

Future Changes in Price and Uptake Affect Cost-Effectiveness Results  Princeton, NJ—October 10, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of a report detailing a new modeling approach that explores the health technology assessment (HTA)

Tagged with: , , ,
Posted in Announcements, ISPOR News & Press, Value in Health

Models To Predict Cardiovascular Disease Risk In Vietnam

Thai Nguyen, Vietnam & Groningen, the Netherlands – The burden of cardiovascular diseases (CVD) is increasing worldwide, including in Vietnam. To make the best use of limited resources, planning of health care interventions is important. Predictive modeling of the risk of CVD

Tagged with: , ,
Posted in Value in Health Regional Issues

Bayesian Meta-Analysis Of Diverse Sources Of Evidence Can Expedite Health Technology Assessments

Leicester, United Kingdom – In health technology assessment, decisions about the availability of new health technologies within a national health service are largely based on effectiveness estimates. Variability in reported outcomes measured by alternative instruments, or extended follow-up time of clinical

Tagged with: , , , , ,
Posted in Methodological Articles, Value in Health

Reviewing Evidence For Use In Cost Effectiveness Models

Sheffield, United Kingdom – Health technology assessments typically require the development of a cost-effectiveness model which necessitates the identification, selection and use of other types of information beyond clinical effectiveness evidence in order to populate the model parameters. The reviewing activity

Tagged with: , , ,
Posted in Comparative Effectiveness Research / Health Technology Assessment, Value in Health
Categories
Follow ISPOR
RSS FeedFriend me on FacebookFollow my company on LinkedInFollow me on TwitterWatch me on YouTube